Jinghai Zhang

Title: Innovations by Jinghai Zhang in Cancer Treatment

Introduction

Jinghai Zhang is a notable inventor based in Shenyang, China. He has made significant contributions to the field of cancer research through his innovative patents. With a total of two patents, Zhang's work focuses on the development of therapeutic methods and agents for cancer prevention and treatment.

Latest Patents

Zhang's latest patents include groundbreaking research on the VGSCβ3 protein. This patent addresses the prevention, treatment, and diagnostic detection of cancers. It involves inhibitors of the VGSCβ3 protein and methods for using this protein to diagnose, prevent, and treat cancer. Additionally, he has developed a method for utilizing a peptide derived from scorpions that possesses analgesic and antitumor activity. This invention outlines the extraction, isolation, and purification of the peptide, which can be synthesized chemically or through bioengineering methods for use as analgesic and antitumor drugs.

Career Highlights

Jinghai Zhang is affiliated with Shenyang Pharmaceutical University, where he continues to advance his research in pharmaceutical sciences. His work has garnered attention for its potential impact on cancer treatment and pain management.

Collaborations

Zhang collaborates with esteemed colleagues, including Yanfeng Liu and Yong Cui, who contribute to his research endeavors.

Conclusion

Jinghai Zhang's innovative patents reflect his commitment to improving cancer treatment and pain relief. His contributions to the field are poised to make a significant impact on medical science and patient care.